Episode 6 of the Medical Affairs Unscripted podcast series recorded by Zipher, now part of Lumanity

Measuring the impact of the medical affairs (MA) organization is not as straightforward as it is for other functions (e.g., increase in revenue or market share for Commercial) and remains a challenge for most pharmaceutical companies today. There have historically been no simple metrics to evaluate the influence of MA, so our host Peg Crowley-Nowick, PhD, MBA met with Meg Heim, RN, MBA, previously Vice President, Global Head of Scientific Engagement Strategy, Operations and Program Management at Sanofi and currently President at Heim Global Consulting, to discuss a methodology she developed and employed to truly measure the effectiveness of the MA organization.

After briefly touching on Meg’s experience in advocacy and policy and its importance in advancing MA, Dr Crowley-Nowick asks Meg to explain what MA has to do to demonstrate impact. The conversation focused on how to measure impact over time and ensure that this resonates throughout an organization. Additionally, Meg addresses the importance of working with vendor partners to fill in gaps in expertise and to provide support services that can prove to be incredibly valuable for insights, decision making, and refining strategy (e.g., data on key opinion leaders). This episode of Medical Affairs Unscripted closes with how to use artificial intelligence to analyze insights to avoid bias and advance medical strategy.

Podcast Series: Medical Affairs Unscripted

Hosted by Dr Peggy Crowley-Nowick, in Medical Affairs Unscripted we explore a range of topics related to the strategic role of medical affairs from the perspective of industry experts. Through these conversations with our guests we will share first hand experience to provide the listener with insights and knowledge about the evolving role of medical affairs.

 

Guest speaker

Meg Heim RN, MBA

President at Heim Global Consulting

Previously Vice President, Global Head of Scientific Engagement Strategy, Operations and Program Management at Sanofi